Holen Sie sich die Stockscreener-App
0.3701
8.28%
-0.0334
Handel nachbörslich:
.36
-0.0101
-2.73%
Finanzdaten der X 4 Pharmaceuticals Inc-Aktie (XFOR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
47.98%
37.29
|
25.20 | 27.21 | 25.80 | 29.30 |
| Interest Income/Expense |
0.64%
1.874
|
1.886 | 1.634 | 1.148 | 1.109 |
| Operating Income/Loss |
47.98%
-37.29
|
-25.20 | -27.21 | -25.80 | -29.30 |
| Nonoperating Income/Loss |
336.94%
-14.46
|
6.102 | 24.93 | -29.89 | 5.288 |
| Income/Loss From Continuing Operations Before Tax |
170.97%
-51.75
|
-19.10 | -2.279 | -55.70 | -24.02 |
| Income Tax Expense/Benefit |
42.42%
0.019
|
0.033 | 0.026 | 0.015 | 0.004 |
| Income/Loss From Continuing Operations After Tax |
170.60%
-51.77
|
-19.13 | -2.305 | -55.71 | -24.02 |
|
Net Income/Loss
|
170.60%
-51.77
|
-19.13 | -2.305 | -55.71 | -24.02 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,732%
199.99
|
7.0615 | 196.99 | 168.74 | 145.97 |
| Diluted Average Shares |
2,732%
199.99
|
7.0615 | 196.99 | 168.74 | 145.97 |
| Basic Earnings Per Share |
188.89%
-0.26
|
-0.09 | -0.01 | -0.33 | -0.16 |
| Diluted Earnings Per Share |
188.89%
-0.26
|
-0.09 | -0.01 | -0.33 | -0.16 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):